Hapvida corrected its accounting methods from 2016 to 2023, affecting its net equity positively by 503 million reais under CPC 50 standards but negatively by 202 million reais under CPC 11. They renegotiated debts worth 2.9 billion reais down to 1.7 billion, stating a 470 million reais positive impact, with a fourth-quarter profit of 514.7 million reais exceeding expectations.
Brazilian healthcare operator Hapvida has made significant accounting adjustments impacting its financial statements from 2016 to 2023. These corrections, guided by CPC 50 standards, have resulted in a positive boost of 503 million reais ($89 million) to the company’s net equity for 2024. However, when using CPC 11 standards, the net equity actually decreased by 202 million reais, as detailed in their recent securities filing.
The accounting corrections encompass various adjustments such as the write-off of deferred tax liabilities and judicial deposits, reassessment of certain asset values, and recognition of deferred revenue related to insurance contracts. Additionally, Hapvida has engaged in a debt renegotiation program initiated in December, settling liabilities worth 2.9 billion reais for only 1.7 billion reais concerning penalties imposed by the regulator ANS and reimbursements owed to Brazil’s public health system.
This debt renegotiation has resulted in a net positive impact of 470 million reais on Hapvida’s financial outcomes. Moreover, the company reported a fourth-quarter adjusted net profit of 514.7 million reais, which exceeded analysts’ expectations, as gathered from a poll by LSEG.
Hapvida’s recent accounting corrections have provided both positive and negative effects on its net equity depending on the accounting standards used. The debt renegotiation has also significantly improved its financial results. These strategic changes reflect an effort to enhance the firm’s financial stability and operational efficiency in the Brazilian healthcare sector.
Original Source: www.tradingview.com
